 |
Home | CVS Caremark’s “Neutral” Rating Reaffirmed at Zacks (CVS) |
 |
CVS Caremark’s “Neutral” Rating Reaffirmed at Zacks (CVS)
|
 |
- August 17, 2012
-
CVS Caremark (NYSE: CVS)‘s stock had its “neutral” rating reiterated by Zacks in a research note issued to investors on Friday. They currently have a $47.00 price target on the stock. CVS has been the subject of a number of other recent research reports. Analysts at Cantor Fitzgerald initiated coverage on shares of CVS Caremark [...]This article (CVS Caremark’s “Neutral” Rating Reaffirmed at Zacks (CVS)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/08/17/cvs-caremarks-neutral-rating-reaffirmed-at-zacks-cvs-2/
|
 |
|
 |
|
 |